LP-211

LP-211
Systematic (IUPAC) name
N-(4-cyanophenylmethyl)-4-(2-diphenyl)-1-piperazinehexanamide
Identifiers
PubChem CID 25107716
ChemSpider 23343345 N
Chemical data
Formula C30H34N4O
Molar mass 466.616 g/mol
 NYesY (what is this?)  (verify)

LP-211 is a drug which acts as a potent and selective agonist at the 5HT7 serotonin receptor, with better brain penetration than older 5-HT7 agonists in the same series, and similar effects in animals.[1][2]

See also

References

  1. Hedlund PB, Leopoldo M, Caccia S, Sarkisyan G, Fracasso C, Martelli G, Lacivita E, Berardi F, Perrone R (August 2010). "LP-211 is a brain penetrant selective agonist for the serotonin 5-HT(7) receptor". Neuroscience Letters 481 (1): 12–6. doi:10.1016/j.neulet.2010.06.036. PMC 2910240. PMID 20600619.
  2. Monti JM (August 2011). "Serotonin control of sleep-wake behavior". Sleep Medicine Reviews 15 (4): 269–81. doi:10.1016/j.smrv.2010.11.003. PMID 21459634.
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.